These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 36499317)

  • 1. Quality of T-Cell Response to SARS-CoV-2 mRNA Vaccine in ART-Treated PLWH.
    Tortellini E; Zingaropoli MA; Mancarella G; Marocco R; Carraro A; Jamhour M; Barbato C; Guardiani M; Dominelli F; Pasculli P; Napoli A; Gaeta A; Mengoni F; Zuccalà P; Belvisi V; Kertusha B; Parente A; Del Borgo C; Vullo V; Ciardi MR; Mastroianni CM; Lichtner M; Latina Covid-Group
    Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36499317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Humoral and cell-mediated immune responses in HIV-vertically infected young patients after three doses of the BNT162b2 mRNA SARS-CoV-2 vaccine.
    Vanetti C; Stracuzzi M; Crivellaro E; Ciciliano F; Garziano M; Fenizia C; Biasin M; Rubinacci V; Amendola A; Tanzi E; Zuccotti GV; Clerici M; Giacomet V; Trabattoni D
    Front Immunol; 2023; 14():1301766. PubMed ID: 38250079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Humoral and Cellular Immune Response Elicited by mRNA Vaccination Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in People Living With Human Immunodeficiency Virus Receiving Antiretroviral Therapy Based on Current CD4 T-Lymphocyte Count.
    Antinori A; Cicalini S; Meschi S; Bordoni V; Lorenzini P; Vergori A; Lanini S; De Pascale L; Matusali G; Mariotti D; Cozzi Lepri A; Gallì P; Pinnetti C; Gagliardini R; Mazzotta V; Mastrorosa I; Grisetti S; Colavita F; Cimini E; Grilli E; Bellagamba R; Lapa D; Sacchi A; Marani A; Cerini C; Candela C; Fusto M; Puro V; Castilletti C; Agrati C; Girardi E; Vaia F;
    Clin Infect Dis; 2022 Aug; 75(1):e552-e563. PubMed ID: 35366316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple sclerosis-disease modifying therapies affect humoral and T-cell response to mRNA COVID-19 vaccine.
    Dominelli F; Zingaropoli MA; Tartaglia M; Tortellini E; Guardiani M; Perri V; Pasculli P; Ciccone F; Malimpensa L; Baione V; Napoli A; Gaeta A; Lichtner M; Conte A; Mastroianni CM; Ciardi MR
    Front Immunol; 2022; 13():1050183. PubMed ID: 36532061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Humoral and Cellular Immune Response Elicited by Two Doses of mRNA BNT162b2 Vaccine Against SARS-CoV-2 in People Living with HIV.
    Vanetti C; Milazzo L; Ardizzone F; Oreni L; Cappelletti G; Trabattoni D; Biasin M
    AIDS Res Hum Retroviruses; 2023 Sep; 39(9):495-499. PubMed ID: 37031355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cluster Analysis Identifies Distinct Patterns of T-Cell and Humoral Immune Responses Evolution Following a Third Dose of SARS-CoV-2 Vaccine in People Living with HIV.
    El Moussaoui M; Desmecht S; Lambert N; Maes N; Braghini J; Marechal N; Quintana C; Briquet K; Gofflot S; Toussaint F; Hayette MP; Vermeersch P; Lutteri L; Grégoire C; Beguin Y; Rahmouni S; Moutschen M; Desmecht D; Darcis G
    Viruses; 2023 Jun; 15(7):. PubMed ID: 37515123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does COVID-19 Vaccination with BNT162b2 Influence HIV-Related Immunological and Virological Markers? Data from 235 Persons Living with HIV at Cotugno Hospital, Naples, Italy: Immune Response After Second and Third Doses, and Influence on Immunovirological Markers.
    Fusco FM; Carleo MA; Sangiovanni N; D'Abbraccio M; Tambaro O; Borrelli F; Viglietti R; Camaioni C; Bruner V; Falanga R; Pisapia R; Palmiero G; Rizzo V; Rosario P; Cuomo N; Spatarella M; Esposito V; Sangiovanni V
    Viral Immunol; 2023 Jun; 36(5):360-365. PubMed ID: 37140991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inactivated SARS-CoV-2 vaccines elicit immunogenicity and T-cell responses in people living with HIV.
    Lv Z; Li Q; Feng Z; Zheng X; NaYin ; Yang H; Gu Q; Ying S; Qi Y; Li X; Wu R; Wu Z; Yu X; Zou N; Qin D; Wan C
    Int Immunopharmacol; 2022 Jan; 102():108383. PubMed ID: 34824035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Humoral immune response to inactivated COVID-19 vaccination at the 3rd month among people living with HIV.
    Wu S; Zou S; Ming F; Wu M; Guo W; Xing Z; Zhang Z; Liu J; Tang W; Liang K
    BMC Infect Dis; 2023 Jan; 23(1):34. PubMed ID: 36670363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SARS-CoV-2 Vaccine-Induced T-Cell Response after Three Doses in People Living with HIV on Antiretroviral Therapy Compared to Seronegative Controls (CTN 328 COVAXHIV Study).
    Alexandrova Y; Yero A; Mboumba Bouassa RS; Comeau E; Samarani S; Brumme ZL; Hull M; Crawley AM; Langlois MA; Angel JB; Cooper CL; Needham J; Lee T; Singer J; Anis AH; Costiniuk CT; Jenabian MA
    Viruses; 2023 Feb; 15(2):. PubMed ID: 36851789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired Functional T-Cell Response to SARS-CoV-2 After Two Doses of BNT162b2 mRNA Vaccine in Older People.
    Demaret J; Corroyer-Simovic B; Alidjinou EK; Goffard A; Trauet J; Miczek S; Vuotto F; Dendooven A; Huvent-Grelle D; Podvin J; Dreuil D; Faure K; Deplanque D; Bocket L; Duhamel A; Labreuche J; Sobaszek A; Hisbergues M; Puisieux F; Labalette M; Lefèvre G
    Front Immunol; 2021; 12():778679. PubMed ID: 34868051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Weak SARS-CoV-2-specific responses of TIGIT-expressing CD8 + T cells in people living with HIV after a third dose of a SARS-CoV-2 inactivated vaccine.
    Jin J; Wang X; Li Y; Yang X; Wang H; Han X; Sun J; Ma Z; Duan J; Zhang G; Huang T; Zhang T; Wu H; Zhang X; Su B
    Chin Med J (Engl); 2023 Dec; 136(24):2938-2947. PubMed ID: 37963586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Six-month humoral response to mRNA SARS-CoV-2 vaccination in patients with multiple sclerosis treated with ocrelizumab and fingolimod.
    Capuano R; Bisecco A; Conte M; Donnarumma G; Altieri M; Grimaldi E; Franci G; Chianese A; Galdiero M; Coppola N; Tedeschi G; Gallo A
    Mult Scler Relat Disord; 2022 Apr; 60():103724. PubMed ID: 35272145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Humoral Immune Response to BNT162b2 Vaccine Is Associated With Circulating CD19+ B Lymphocytes and the Naïve CD45RA to Memory CD45RO CD4+ T Helper Cells Ratio in Hemodialysis Patients and Kidney Transplant Recipients.
    Duni A; Markopoulos GS; Mallioras I; Pappas H; Pappas E; Koutlas V; Tzalavra E; Baxevanos G; Priska S; Gartzonika K; Mitsis M; Dounousi E
    Front Immunol; 2021; 12():760249. PubMed ID: 34925330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MAIT cell compartment characteristics are associated with the immune response magnitude to the BNT162b2 mRNA anti-SARS-CoV-2 vaccine.
    Boulouis C; Kammann T; Cuapio A; Parrot T; Gao Y; Mouchtaridi E; Wullimann D; Lange J; Chen P; Akber M; Rivera Ballesteros O; Muvva JR; ; Smith CIE; Vesterbacka J; Kieri O; Nowak P; Bergman P; Buggert M; Ljunggren HG; Aleman S; Sandberg JK
    Mol Med; 2022 May; 28(1):54. PubMed ID: 35562666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenicity to COVID-19 mRNA vaccine third dose in people living with HIV.
    Vergori A; Cozzi Lepri A; Cicalini S; Matusali G; Bordoni V; Lanini S; Meschi S; Iannazzo R; Mazzotta V; Colavita F; Mastrorosa I; Cimini E; Mariotti D; De Pascale L; Marani A; Gallì P; Garbuglia A; Castilletti C; Puro V; Agrati C; Girardi E; Vaia F; Antinori A;
    Nat Commun; 2022 Aug; 13(1):4922. PubMed ID: 35995780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-2-mediated CD4 T-cell activation correlates highly with effective serological and T-cell responses to SARS-CoV-2 vaccination in people living with HIV.
    Gupta A; Righi E; Konnova A; Sciammarella C; Spiteri G; Van Averbeke V; Berkell M; Hotterbeekx A; Sartor A; Mirandola M; Malhotra-Kumar S; Azzini AM; Pezzani D; Monaco MGL; Vanham G; Porru S; Tacconelli E; Kumar-Singh S
    J Med Virol; 2024 Aug; 96(8):e29820. PubMed ID: 39056205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune responses to mRNA-based vaccines given as a third COVID-19 vaccine dose in people living with HIV-a literature review.
    Knudsen ML; Nielsen SD; Heftdal LD
    APMIS; 2024 Apr; 132(4):236-244. PubMed ID: 38275143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relatively preserved functional immune capacity with standard COVID-19 vaccine regimen in people living with HIV.
    Hung CY; Hsiao SH; Huang CG; Chang CS; Chen GY; Huang YL; Dutta A; Huang CT
    Front Immunol; 2023; 14():1204314. PubMed ID: 37731482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Six-month humoral response to BNT162b2 mRNA COVID-19 vaccine in people with multiple sclerosis treated with natalizumab.
    Altieri M; Capuano R; Conte M; Donnarumma G; Grimaldi E; Coppola N; Galdiero M; d'Ambrosio A; Tedeschi G; Gallo A
    Neurol Sci; 2022 May; 43(5):2947-2949. PubMed ID: 35171373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.